{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:55:15Z","timestamp":1762001715368},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,8,4]],"date-time":"2012-08-04T00:00:00Z","timestamp":1344038400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00383-012-3139-x","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T14:42:02Z","timestamp":1344004922000},"page":"887-891","source":"Crossref","is-referenced-by-count":10,"title":["Can we predict the prognosis of resectable hepatoblastoma from serum alpha-fetoprotein response during preoperative chemotherapy?"],"prefix":"10.1007","volume":"28","author":[{"given":"Hiroaki","family":"Fukuzawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Urushihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Mitsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Aoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Yamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromu","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,4]]},"reference":[{"key":"3139_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00383-010-2708-0","volume":"27","author":"T Hisiki","year":"2011","unstructured":"Hisiki T, Matsunaga T, Sasaki F et al (2011) Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT. Pediatr Surg Int 27:1\u20138","journal-title":"Pediatr Surg Int"},{"key":"3139_CR2","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/pbc.22088","volume":"53","author":"RL Meyers","year":"2009","unstructured":"Meyers RL, Rowland JR, Krailo M et al (2009) Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer 53:1016\u20131022","journal-title":"Pediatr Blood Cancer"},{"key":"3139_CR3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/cncr.10632","volume":"95","author":"J Fuchs","year":"2002","unstructured":"Fuchs J, Rydzynski J, Von Schweinitz D et al (2002) Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB94. Cancer 95:172\u2013182","journal-title":"Cancer"},{"key":"3139_CR4","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.1997.15.3.1190","volume":"15","author":"JM Tornout Van","year":"1997","unstructured":"Van Tornout JM, Buckley JD, Quinn JJ et al (1997) Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children\u2019s Cancer Group. J Clin Oncol 15:1190\u20131197","journal-title":"J Clin Oncol"},{"key":"3139_CR5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jpedsurg.2009.10.023","volume":"45","author":"HN Lovvorn 3rd","year":"2010","unstructured":"Lovvorn HN 3rd, Ayers D, Zhao Z et al (2010) Defining hepatoblastoma responsiveness to induction therapy as measured by tumor volume and serum alpha-fetoprotein kinetics. J Pediatr Surg 45:121\u2013128","journal-title":"J Pediatr Surg"},{"key":"3139_CR6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/pbc.23069","volume":"57","author":"KN Koh","year":"2011","unstructured":"Koh KN, Park M, Kim BE et al (2011) Prognostic implication of serum alpha-fetoprotein response during treatment of hepatoblastoma. Pediatr Blood Cancer 57:554\u2013560","journal-title":"Pediatr Blood Cancer"},{"key":"3139_CR7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/jpsu.2002.32886","volume":"37","author":"F Sasaki","year":"2002","unstructured":"Sasaki F, Matsunaga T, Iwafuchi M et al (2002) Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protcol-1: a report from the Japanese Study Group for Pediatric Liver tumor. J Pediatr Surg 37:851\u2013856","journal-title":"J Pediatr Surg"},{"key":"3139_CR8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejca.2003.06.003","volume":"40","author":"G Perilongo","year":"2004","unstructured":"Perilongo G, Shafford E, Maibach R et al (2004) Risk-adapted treatment for childhood hepatoblastoma: final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2. Eur J Cancer 40:411\u2013421","journal-title":"Eur J Cancer"},{"key":"3139_CR9","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1200\/JCO.2002.07.400","volume":"20","author":"HM Katzenstein","year":"2002","unstructured":"Katzenstein HM, London WB, Douglass EC et al (2002) Treatment of unresectable and metastatic hepatoblastoma: a Paediatric Oncology Group Phase II Study. J Clin Oncol 20:3438\u20133444","journal-title":"J Clin Oncol"},{"key":"3139_CR10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00383-002-0906-0","volume":"19","author":"T Matsunaga","year":"2003","unstructured":"Matsunaga T, Sasaki F, Ohira M et al (2003) Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma. Pediatr Surg Int 19:142\u2013146","journal-title":"Pediatr Surg Int"},{"key":"3139_CR11","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1200\/JCO.2005.02.6013","volume":"24","author":"MH Malogolowkin","year":"2006","unstructured":"Malogolowkin MH, Katzenstein H, Krailo MD et al (2006) Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. J Clin Oncol 24:2879\u20132884","journal-title":"J Clin Oncol"},{"key":"3139_CR12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/pbc.22088","volume":"53","author":"LM Meyers","year":"2009","unstructured":"Meyers LM, Rowland JR, Krailo M et al (2009) Predictive power of pretreatment prognostic factors in children with hepatoblastoma: A report from the children\u2019s oncology group. Pediatr Blood Cancer 53:1016\u20131022","journal-title":"Pediatr Blood Cancer"},{"key":"3139_CR13","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0959-8049(97)00095-6","volume":"33","author":"D Schweinitz von","year":"1997","unstructured":"von Schweinitz D, Byrd DJ, Hecker H et al (1997) Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. Eur J Cancer 33:1243\u20131249","journal-title":"Eur J Cancer"},{"key":"3139_CR14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejca.2007.11.022","volume":"44","author":"M Ioris De","year":"2008","unstructured":"De Ioris M, Brugieres L, Zimmermann A et al (2008) Hepatoblastoma with low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer 44:545\u2013550","journal-title":"Eur J Cancer"},{"key":"3139_CR15","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0959-8049(00)00074-5","volume":"36","author":"J Browo","year":"2000","unstructured":"Browo J, Perilongo G, Shafford E et al (2000) Pretreatment prognostic factors for children with hepatoblastoma\u2014result from the International Society of Paediatric Oncology (SIOP) study SIOPEL1. Eur J Cancer 36:1418\u20131425","journal-title":"Eur J Cancer"},{"key":"3139_CR16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s002680020052","volume":"25","author":"SE Jung","year":"2001","unstructured":"Jung SE, Kim KH, Kim MY et al (2001) Clinical characteristics and prognosis of patients with hepatoblastoma. World J Surg 25:126\u2013130","journal-title":"World J Surg"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-012-3139-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00383-012-3139-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-012-3139-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T08:13:19Z","timestamp":1594541599000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00383-012-3139-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,4]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["3139"],"URL":"https:\/\/doi.org\/10.1007\/s00383-012-3139-x","relation":{},"ISSN":["0179-0358","1437-9813"],"issn-type":[{"value":"0179-0358","type":"print"},{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,4]]}}}